Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Optom Vis Sci. 2017 Jan;94(1):20–32. doi: 10.1097/OPX.0000000000000898

Figure 6.

Figure 6

Treatment with rAAV.EpoR76E alters nitrotyrosine immunofluorescence in the inner retina of Balb/c mice after blast. A-C) Representative fluorescence micrographs of nitrotyrosine immunolabeling in retinas from mice injected with: (A) rAAV.eGFP, (B) rAAV.EpoR76E prior to blast, or (C) rAAV.EpoR76E after blast. Scale bar represents 50μm and applies to all images. (D) Bar graph of quantification of anti-nitrotyrosine immunofluorescence in the inner retina at 1-month post-blast. Pre-blast group were injected with rAAV.EpoR76E 1-month prior to blast. Post-blast group was injected with rAAV.EpoR76E 1 day after blast. There was no difference in the pre- or post-blast rAAV.eGFP groups so they were combined. *p<0.05, **p<0.01.